Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Dulaglutide 0.75mg's trials
GLUMINS
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
Dulaglutide 0.75mg subcutaneous injection
Ongoing
Recruiting
Phase 4
Open NCT06324461 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
GLUMINS · Trial Tracker · ComplyRx
